Identification of cancer risk groups through multi-omics integration using autoencoder and tensor analysis.
- Publisher:
- NATURE PORTFOLIO
- Publication Type:
- Journal Article
- Citation:
- Sci Rep, 2024, 14, (1), pp. 11263
- Issue Date:
- 2024-05-17
Open Access
Copyright Clearance Process
- Recently Added
- In Progress
- Open Access
This item is open access.
Full metadata record
Field | Value | Language |
---|---|---|
dc.contributor.author |
Braytee, A https://orcid.org/0000-0003-2561-6496 |
|
dc.contributor.author | He, S | |
dc.contributor.author | Tang, S | |
dc.contributor.author | Sun, Y | |
dc.contributor.author | Jiang, X | |
dc.contributor.author | Yu, X | |
dc.contributor.author | Khatri, I | |
dc.contributor.author |
Chaturvedi, K https://orcid.org/0000-0001-9940-1565 |
|
dc.contributor.author | Prasad, M | |
dc.contributor.author | Anaissi, A | |
dc.date.accessioned | 2024-09-22T03:37:43Z | |
dc.date.available | 2024-04-12 | |
dc.date.available | 2024-09-22T03:37:43Z | |
dc.date.issued | 2024-05-17 | |
dc.identifier.citation | Sci Rep, 2024, 14, (1), pp. 11263 | |
dc.identifier.issn | 2045-2322 | |
dc.identifier.issn | 2045-2322 | |
dc.identifier.uri | http://hdl.handle.net/10453/180904 | |
dc.description.abstract | Identifying cancer risk groups by multi-omics has attracted researchers in their quest to find biomarkers from diverse risk-related omics. Stratifying the patients into cancer risk groups using genomics is essential for clinicians for pre-prevention treatment to improve the survival time for patients and identify the appropriate therapy strategies. This study proposes a multi-omics framework that can extract the features from various omics simultaneously. The framework employs autoencoders to learn the non-linear representation of the data and applies tensor analysis for feature learning. Further, the clustering method is used to stratify the patients into multiple cancer risk groups. Several omics were included in the experiments, namely methylation, somatic copy-number variation (SCNV), micro RNA (miRNA) and RNA sequencing (RNAseq) from two cancer types, including Glioma and Breast Invasive Carcinoma from the TCGA dataset. The results of this study are promising, as evidenced by the survival analysis and classification models, which outperformed the state-of-the-art. The patients can be significantly (p-value<0.05) divided into risk groups using extracted latent variables from the fused multi-omics data. The pipeline is open source to help researchers and clinicians identify the patients' risk groups using genomics. | |
dc.format | Electronic | |
dc.language | eng | |
dc.publisher | NATURE PORTFOLIO | |
dc.relation.ispartof | Sci Rep | |
dc.relation.isbasedon | 10.1038/s41598-024-59670-8 | |
dc.rights | info:eu-repo/semantics/openAccess | |
dc.subject.mesh | Humans | |
dc.subject.mesh | Genomics | |
dc.subject.mesh | DNA Copy Number Variations | |
dc.subject.mesh | DNA Methylation | |
dc.subject.mesh | Neoplasms | |
dc.subject.mesh | MicroRNAs | |
dc.subject.mesh | Female | |
dc.subject.mesh | Biomarkers, Tumor | |
dc.subject.mesh | Glioma | |
dc.subject.mesh | Breast Neoplasms | |
dc.subject.mesh | Multiomics | |
dc.subject.mesh | Humans | |
dc.subject.mesh | Neoplasms | |
dc.subject.mesh | Glioma | |
dc.subject.mesh | Breast Neoplasms | |
dc.subject.mesh | MicroRNAs | |
dc.subject.mesh | Genomics | |
dc.subject.mesh | DNA Methylation | |
dc.subject.mesh | Female | |
dc.subject.mesh | DNA Copy Number Variations | |
dc.subject.mesh | Biomarkers, Tumor | |
dc.subject.mesh | Multiomics | |
dc.subject.mesh | Humans | |
dc.subject.mesh | Genomics | |
dc.subject.mesh | DNA Copy Number Variations | |
dc.subject.mesh | DNA Methylation | |
dc.subject.mesh | Neoplasms | |
dc.subject.mesh | MicroRNAs | |
dc.subject.mesh | Female | |
dc.subject.mesh | Biomarkers, Tumor | |
dc.subject.mesh | Glioma | |
dc.subject.mesh | Breast Neoplasms | |
dc.subject.mesh | Multiomics | |
dc.title | Identification of cancer risk groups through multi-omics integration using autoencoder and tensor analysis. | |
dc.type | Journal Article | |
utslib.citation.volume | 14 | |
utslib.location.activity | England | |
pubs.organisational-group | University of Technology Sydney | |
pubs.organisational-group | University of Technology Sydney/Faculty of Engineering and Information Technology | |
pubs.organisational-group | University of Technology Sydney/Faculty of Engineering and Information Technology/School of Computer Science | |
utslib.copyright.status | open_access | * |
dc.rights.license | This work is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0). To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/ | |
dc.date.updated | 2024-09-22T03:37:40Z | |
pubs.issue | 1 | |
pubs.publication-status | Published online | |
pubs.volume | 14 | |
utslib.citation.issue | 1 |
Abstract:
Identifying cancer risk groups by multi-omics has attracted researchers in their quest to find biomarkers from diverse risk-related omics. Stratifying the patients into cancer risk groups using genomics is essential for clinicians for pre-prevention treatment to improve the survival time for patients and identify the appropriate therapy strategies. This study proposes a multi-omics framework that can extract the features from various omics simultaneously. The framework employs autoencoders to learn the non-linear representation of the data and applies tensor analysis for feature learning. Further, the clustering method is used to stratify the patients into multiple cancer risk groups. Several omics were included in the experiments, namely methylation, somatic copy-number variation (SCNV), micro RNA (miRNA) and RNA sequencing (RNAseq) from two cancer types, including Glioma and Breast Invasive Carcinoma from the TCGA dataset. The results of this study are promising, as evidenced by the survival analysis and classification models, which outperformed the state-of-the-art. The patients can be significantly (p-value<0.05) divided into risk groups using extracted latent variables from the fused multi-omics data. The pipeline is open source to help researchers and clinicians identify the patients' risk groups using genomics.
Please use this identifier to cite or link to this item:
Download statistics for the last 12 months
Not enough data to produce graph